Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids
AssigneeAbbott Laboratories
InventorPhilip G. Mattingly
Life of this patent
Estimating the term…
Abstract
Novel tethered hapten intermediates and related conjugates based on 3- phenyl-1-adamantaneacetic acid, as well as methods for making and using such conjugates. Haptens based on the above core structure may be substituted at any position on the phenyl ring, especially at the para position. Using tethered intermediates, immunogens, tracers, solid supports and labeled oligonucleotides are all described; as are methods for using the intermediates to prepare the conjugates, methods of using the conjugates to make and purify anitbodies, as assay tracers, and in nucleic acid hybridization assays. Kits containing haptenated oligonucleotides and anti-hapten conjugates are also described.
Claims12
A conjugate compound having the following structure:
- ##STR23## wherein a and a' are independently selected from the group consisting of:
- hydrogen, C.sub.1 -C.sub.10 -alkyl, C.sub.1 -C.sub.10 -alkoxy, C.sub.1 -C.sub.10 -alkylthio, halo-C.sub.1 -C.sub.10 -alkyl, C.sub.1 -C.sub.10 -alkylamino, di-(C.sub.1 -C.sub.10 -alkyl )amino, aryl-C.sub.1 -C.sub.10 -alkyl, optionally substituted aryl, halogen, amino, carboxy, carboxamido, hydroxy, mercapto, nitro, nitroso, sulfo, phospho and protected forms thereof;
- or
- alternatively a and a' when taken together with the carbons to which they are joined form a fused ring;
- Z is alkylene of from 1 to about 10 atoms;
- A is a linking moiety of the formula --L-- wherein L is spacer group consisting of from 1 to about 50 atoms;
- and
- Q is an immunogenicity conferring carrier molecule, a detectable label, an oligonucleotide or a solid support.
Dependencies are inferred from the claim text.